Call Options

14 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$39.12 - $52.44 $35,208 - $47,196
-900 Reduced 90.0%
100 $0
Q4 2023

Jan 18, 2024

BUY
$21.39 - $49.64 $10,695 - $24,820
500 Added 100.0%
1,000 $4,000
Q3 2023

Nov 07, 2023

SELL
$15.81 - $27.8 $67,983 - $119,540
-4,300 Reduced 89.58%
500 $0
Q2 2023

Jul 18, 2023

BUY
$16.32 - $21.15 $76,704 - $99,405
4,700 Added 4700.0%
4,800 $0
Q1 2023

May 01, 2023

SELL
$16.88 - $34.24 $150,232 - $304,736
-8,900 Reduced 98.89%
100 $0
Q4 2022

Feb 07, 2023

SELL
$22.21 - $30.25 $237,647 - $323,675
-10,700 Reduced 54.31%
9,000 $13,000
Q3 2022

Oct 25, 2022

BUY
$4.3 - $30.85 $82,560 - $592,320
19,200 Added 3840.0%
19,700 $65,000
Q1 2022

Apr 14, 2022

BUY
$6.13 - $12.24 $1,226 - $2,448
200 Added 66.67%
500 $0
Q1 2021

Apr 26, 2021

SELL
$20.25 - $39.49 $62,775 - $122,419
-3,100 Reduced 91.18%
300 $0
Q4 2020

Jan 21, 2021

SELL
$21.17 - $32.61 $21,170 - $32,610
-1,000 Reduced 22.73%
3,400 $3,000
Q3 2020

Oct 27, 2020

BUY
$18.13 - $30.61 $77,959 - $131,623
4,300 Added 4300.0%
4,400 $9,000
Q2 2020

Jul 22, 2020

SELL
$14.41 - $25.35 $4,323 - $7,605
-300 Reduced 75.0%
100 $0
Q1 2020

May 07, 2020

BUY
$13.16 - $22.9 $3,948 - $6,870
300 Added 300.0%
400 $0
Q4 2019

Feb 06, 2020

BUY
$19.53 - $25.5 $1,953 - $2,550
100 New
100 $0

Others Institutions Holding RYTM

About RHYTHM PHARMACEUTICALS, INC.


  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $3.13B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.